# 1cP-MiPLA
*Source: https://en.wikipedia.org/wiki/1cP-MiPLA*

1cP-MiPLA, also known as 1-cyclopropanoyl-MiPLA or 1-cyclopropanoyl-N-methyl-N-isopropyllysergamide, is a presumed psychedelic drug of the lysergamide family. It is the 1-cyclopropanoyl derivative of MiPLA (N-methyl-N-isopropyllysergamide) and is thought to be a prodrug of MiPLA. 1cP-MiPLA has been encountered as a novel designer drug online and in Japan.

## Use and effects

1cP-MiPLA has been sold in the form of blotter tabs containing doses of 200 Î¼g per tab. Data on the effects of 1cP-MiPLA at different doses are not available.

## Interactions

## Pharmacology

1cP-MiPLA is assumed to act as a prodrug of MiPLA via deacylation. Relatedly, it is assumed to act as a serotonin receptor agonist, including of the serotonin 5-HT2A receptor, and to be a serotonergic psychedelic.

## Chemistry

### Analogues

Analogues of 1cP-MiPLA include MiPLA, 1P-MiPLA, and 1cP-AL-LAD, among others.

## History

1cP-MiPLA was first encountered as a novel designer drug online in 2020 and in Japan by 2022.

## Society and culture

### Legal status

#### Russia

1cP-MiPLA is a schedule I controlled substance in Russia.
